Overview
Dr. Magenau is currently an Assistant Professor at the University of Michigan and the Adult Clinical BMT director of the Blood and Marrow Transplantation Program. He holds a Bachelor of Science in Biology from Pennsylvania State University, and obtained his M.D. from the Temple University in Philadelphia, Pennsylvania. Dr. Magenau then trained in internal medicine at the University of Illinois in Chicago.Dr. Magenau is the lead clinical investigator on several trials including experience in clinical HCT, responsible research practices, team science, and conducting multicenter prospective HCT clinical trials in high risk populations (Acute Myeloid Leukemia not in remission at time of HCT). He also has a background in developing, performing, and monitoring HCT studies that integrate immune analysis of human samples.
Dr. Magenau is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Magenau is board certified in Hematology. Dr. Magenau is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1540 E Hospital Dr, Floor 7 Reception B, Ann Arbor, MI 48109
Additional Areas of Focus
Dr. Magenau has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Rogel Cancer Center
Rashmi Chugh is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.
Rogel Cancer Center
Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology. Dr. Worden is currently accepting new patients.
University Of Michigan Medical Center
Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.
Frequently Asked Questions about Dr. John M. Magenau
How do I make an appointment with Dr. John M. Magenau?
You can book an appointment with Dr. John M. Magenau by calling their office at 734-647-8902. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John M. Magenau a top-rated expert for Graft Versus Host Disease (GvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John M. Magenau is classified as an Distinguished expert for Graft Versus Host Disease (GvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John M. Magenau specialize in?
While Dr. John M. Magenau is a Hematology, they have specific expertise in Graft Versus Host Disease (GvHD), Multiple Myeloma, and Chronic B-Cell Leukemia (CBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. John M. Magenau accept my insurance?
Dr. John M. Magenau accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-647-8902 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Graft Versus Host Disease (GvHD)Dr. Magenau isDistinguished. Learn about Graft Versus Host Disease (GvHD).
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Magenau isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Magenau isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Magenau isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Magenau isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Magenau isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Lymphocytic Leukemia (CLL)Dr. Magenau isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Classical Hodgkin LymphomaDr. Magenau isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Magenau isAdvanced. Learn about Hodgkin Lymphoma.
- Multiple MyelomaDr. Magenau isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Magenau isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisDr. Magenau isAdvanced. Learn about Myelofibrosis.
- Richter SyndromeDr. Magenau isAdvanced. Learn about Richter Syndrome.
- Smoldering Multiple MyelomaDr. Magenau isAdvanced. Learn about Smoldering Multiple Myeloma.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Magenau isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Magenau isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Magenau isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Magenau isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Aplastic AnemiaDr. Magenau isExperienced. Learn about Aplastic Anemia.
- Bone Marrow AspirationDr. Magenau isExperienced. Learn about Bone Marrow Aspiration.
- Castleman DiseaseDr. Magenau isExperienced. Learn about Castleman Disease.
- Chronic Familial NeutropeniaDr. Magenau isExperienced. Learn about Chronic Familial Neutropenia.
- Chronic Myelogenous Leukemia (CML)Dr. Magenau isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Chronic Myelomonocytic Leukemia (CMML)Dr. Magenau isExperienced. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Magenau isExperienced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Magenau isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Essential ThrombocythemiaDr. Magenau isExperienced. Learn about Essential Thrombocythemia.
- Febrile NeutropeniaDr. Magenau isExperienced. Learn about Febrile Neutropenia.
- Hemophagocytic LymphohistiocytosisDr. Magenau isExperienced. Learn about Hemophagocytic Lymphohistiocytosis.
- Large-Cell Immunoblastic LymphomaDr. Magenau isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Magenau isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Midline Lethal GranulomaDr. Magenau isExperienced. Learn about Midline Lethal Granuloma.
- Multicentric Castleman Disease (MCD)Dr. Magenau isExperienced. Learn about Multicentric Castleman Disease (MCD).
- Myeloproliferative Neoplasms (MPN)Dr. Magenau isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Non-Hodgkin LymphomaDr. Magenau isExperienced. Learn about Non-Hodgkin Lymphoma.
- Philadelphia-Negative Chronic Myeloid Leukemia
- Primary Immunodeficiency (PID)Dr. Magenau isExperienced. Learn about Primary Immunodeficiency (PID).
- Primary Lymphoma of the BrainDr. Magenau isExperienced. Learn about Primary Lymphoma of the Brain.
- Prolymphocytic LeukemiaDr. Magenau isExperienced. Learn about Prolymphocytic Leukemia.
- Pure Red Cell AplasiaDr. Magenau isExperienced. Learn about Pure Red Cell Aplasia.
- Relapsed Refractory Multiple Myeloma (RRMM)
- T-Cell LymphomaDr. Magenau isExperienced. Learn about T-Cell Lymphoma.
- ThrombocytopeniaDr. Magenau isExperienced. Learn about Thrombocytopenia.
- Transient Erythroblastopenia of ChildhoodDr. Magenau isExperienced. Learn about Transient Erythroblastopenia of Childhood.
- Unicentric Castleman Disease (UCD)Dr. Magenau isExperienced. Learn about Unicentric Castleman Disease (UCD).
- Virus Associated Hemophagocytic SyndromeDr. Magenau isExperienced. Learn about Virus Associated Hemophagocytic Syndrome.